comparemela.com

StockNews.com downgraded shares of CEL-SCI (NYSE:CVM – Free Report) from a hold rating to a sell rating in a research note published on Monday morning. CEL-SCI Price Performance Shares of CVM stock opened at $1.71 on Monday. CEL-SCI has a 1-year low of $1.68 and a 1-year high of $5.42. The company has a current […]

Related Keywords

Switzerland ,Swiss , ,Swiss National Bank ,Geode Capital Management ,Pricet Rowe Associates Inc ,Free Report ,Get Free Report ,Capital Management ,National Bank ,Leukocyte Interleukin ,Cel Sci ,Nyse Cvm ,Icvm ,Medical ,Downgrade ,Stocknews Com ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.